(Q36967293)

17 August 2017

1 reference

title

Update on clindamycin in the management of bacterial, fungal and protozoal infections (English)

1 reference

17 August 2017

1 reference

1

David Guay

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

14

1 reference

17 August 2017

page(s)

2401-2444

1 reference

Lincosamides: chemical structure, biosynthesis, mechanism of action, resistance, and applications

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Lincomycin, clindamycin and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Simple method for the assay of clindamycin in human plasma by reversed-phase high-performance liquid chromatography with UV detector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Quantitative analysis of clindamycin in human plasma by liquid chromatography/electrospray ionisation tandem mass spectrometry using d1-N-ethylclindamycin as internal standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

A plastid organelle as a drug target in apicomplexan parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

The effects of anti-bacterials on the malaria parasite Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Immunomodulating effects of antibiotics: literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Group B streptococci exposed to rifampin or clindamycin (versus ampicillin or cefotaxime) stimulate reduced production of inflammatory mediators by murine macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

In-vivo effects of clindamycin on polymorphonuclear leucocyte phagocytosis and killing of gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

In-vivo effects of clindamycin on neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin in malaria treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Increasing antibiotic resistance of streptococcus species in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Erythromycin and clindamycin resistance in group B streptococcal clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antimicrobial susceptibility of viridans group streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antibiotic resistance in exopolysaccharide-forming Staphylococcus epidermidis clinical isolates from orthopaedic implant infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Bacteroides fragilis group: trends in resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Identification of bacteria in acute endodontic infections and their antimicrobial susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin in dentistry: more than just effective prophylaxis for endocarditis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Mode of action and mechanisms of resistance for antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

In vitro metabolism of clindamycin in human liver and intestinal microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Results of a pilot trial comparing prolonged intravenous antibiotics with sequential intravenous/oral antibiotics for children with perforated appendicitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Gentamicin and clindamycin therapy in postpartum endometritis: the efficacy of daily dosing versus dosing every 8 hours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Prophylaxis with cefazolin plus clindamycin in clean-contaminated maxillofacial surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Therapeutic responses to antibacterial drugs in vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

New uses of older antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Ventilator-associated pneumonia: diagnosis, treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Practice guidelines for the management of bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Strategies for the management of bacterial brain abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Treatment of Chlamydia trachomatis infections in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antibiotic selection in obstetrics: making cost-effective choices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Diagnosis and treatment of diabetic foot infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin in the treatment of group G beta-haemolytic streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin and rifampicin combination therapy for hidradenitis suppurativa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Treatment of community-associated methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin-resistant Streptococcus pyogenes: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antibiotic therapy--managing odontogenic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin and dentistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

21 January 2018

Pneumocystis pneumonia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Pneumonia in the immunocompromised pediatric cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

The management of Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Treatment of malaria in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin as an antimalarial drug: review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Therapeutic approaches for AIDS-related toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

The effect of oral decontamination with clindamycin palmitate on the incidence of bacteremia after esophageal dilation: a prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clostridium difficile: responding to a new threat from an old enemy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clinical practice. Antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antimicrobial therapy of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Neuromuscular blockade after clindamycin administration: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Prolongation of neuromuscular blocking effect of vecuronium by antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Synthesis and antimicrobial activity of clindamycin analogs: pirlimycin, a potent antibacterial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Macrolide and lincosamide resistance genes of environmental streptococci from bovine milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide-lincosamide resistance phenotypes and genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994-2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Prolongation of a pancuronium-induced neuromuscular blockade by clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

Clindamycin in Recurrent Group A Streptococcal Pharyngotonsillitis– An Alternative to Tonsillectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.14.2401

10.1517/14656566.8.14.2401

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference